PDA brings its Cell and Gene Pharmaceutical Products Conference back to Tokyo for a two-day session, –, the latest instance of a recurring annual event on regulatory and manufacturing questions across cell and gene therapies.
Date and format
- Date: 17–18 November 2026
- Format: in person, Tokyo, Japan (venue not yet confirmed)
- Organizer: PDA (Parenteral Drug Association)
- Registration: Standard Registration USD 499 (member) / USD 199 (government, health authority, academic) / USD 699 (non-member), per PDA's own event page at verification
What it covers
PDA has run this Tokyo cell and gene conference annually, and past editions have focused on regenerative medicine and advanced therapy medicinal products, including cell-processed products, process development and manufacturing. The 2027 edition's published agenda — a useful signal for the kind of programming PDA builds around this series, though not a confirmation of 2026's own agenda — includes regulatory sessions with Japan's PMDA and a track on automation and robotics in cell and gene therapy manufacturing.
Who should attend
Regulatory affairs, quality and CMC professionals at companies developing or manufacturing cell and gene therapy products, particularly teams navigating both global and Japan-specific regulatory expectations through PMDA. For a broader look at advanced therapy manufacturing, EMA's workshop on bacteriophage therapy covers a related frontier in biologics regulation. Device-side regulatory teams may also want AAMI neXus 2027, and the full events directory lists everything we have verified.
Frequently asked questions
When and where is the PDA Cell and Gene Pharmaceutical Products Conference 2026?
17–18 November 2026, in Tokyo, Japan, per PDA's own event page. The specific venue was not stated in the pages we reviewed.
Who organizes it?
PDA (the Parenteral Drug Association). It is the latest instance of a recurring annual Tokyo conference on cell and gene therapy products that PDA has run in past years with the Japan Pharmaceutical Society for PDA.
What does it cost to attend?
PDA's own event page lists Standard Registration (in effect from 17 October 2026) at USD 499 for PDA members, USD 199 for government, health authority and academic members, and USD 699 for non-members. Confirm current pricing with PDA before registering.
What does the conference cover?
PDA's Tokyo cell and gene series has previously covered regenerative medicine and advanced therapy medicinal products, including cell-processed products and process development; the 2026 session-by-session agenda was not published in the sources we reviewed at verification.
Sources & further reading
- PDA. Cell and Gene Pharmaceutical Products Conference 2026 — event listing, 17-18 November 2026, Tokyo. pda.org
- PDA. Cell and Gene Pharmaceutical Products Conference 2027 — next edition in the same recurring series. pda.org
Event details are published by the organizer and can change. This listing was verified via WebSearch corroboration of PDA's own event pages rather than a direct fetch, because this session's network egress could not reach pda.org directly — confirm date, venue and registration with PDA before making plans. Last verified 21 October 2026.
